Previously, Ben Swarts, Sloan Siegrist and colleagues developed light-activated chemical probes that mimic some of these compounds and studied how they might interact with a host's immune cells.

Ophthalmologists were asked as to whether they performed cycloablative therapy using the ‘G-probe’ and whether they reused the G-probe.